National Technical Reports Library

Details

Statement of Dr. John F. Finklea, Director, National Institute for Occupational Safety and Health, Center for Disease Control, Department of Health, Education, and Welfare Before the Subcommittee on Agricultural Research and General Legislation, Senate Committee on Agriculture, Nutrition, and Forestry, December 13, 1977.

PB90130972

Publication Date	1977
Page Count	10
Abstract	The statement concerned the National Institute for Occupational Safety and Health (NIOSH) investigation of occupational exposure to dibromochloropropane (96128) (DBCP) and possible reduced sperm counts among workers handling the compound. Due to the concern of one worker, a chemical company, the Oxy Chem facility in Lathrop, California, contacted NIOSH for assistance in determining whether a health problem existed at their facility. Research indicated that there was a problem and resulted in the identification of DBCP as the offending agent. Confirmation was sought by testing workers at other sites involved in the production of the pesticide. Their research supported the findings that DBCP was the agent responsible for the testicular toxicity. Literature studies revealed DBCP to be an animal carcinogen and a relatively potent mutagen as well. A proposed emergency standard for occupational exposure to DBCP was submitted to the Occupational Safety and Health Administration (OSHA) in early September of 1977 setting an exposure limit and requiring medical surveillance guidelines. A symposium on DBCP was held so that all interested parties might share available data. All participants agreed to the need for a registry of individuals exposed to DBCP. Research has now spread to the possible reproductive effects of exposure to other chemicals similar in structure to DBCP.
Keywords	Environmental surveys Industrial medicine Pesticides Government policies Chemical industry Exposure Toxicity Inspection Hazardous materials Occupational diseases Genital diseases Standards Dibromochloropropane Toxic substances Occupational safety and health Testimony Maximum permissible exposure level CAS 96-12-8
Source Agency	National Institute for Occupational Safety and Health
NTIS Subject Category	57U - Public Health & Industrial Medicine 57Y - Toxicology 68G - Environmental Health & Safety 94D - Job Environment 41I - Job Environment
Corporate Authors	National Inst. for Occupational Safety and Health, Cincinnati, OH.
Document Type	Technical Report
NTIS Issue Number	199008

Statement of Dr. John F. Finklea, Director, National Institute for Occupational Safety and Health, Center for Disease Control, Department of Health, Education, and Welfare Before the Subcommittee on Agricultural Research and General Legislation, Senate Committee on Agriculture, Nutrition, and Forestry, December 13, 1977.

Statement of Dr. John F. Finklea, Director, National Institute for Occupational Safety and Health, Center for Disease Control, Department of Health, Education, and Welfare Before the Subcommittee on Agricultural Research and General Legislation, Senate Committee on Agriculture, Nutrition, and Forestry, December 13, 1977.
PB90130972

Publication Date	1977
Page Count	10
Abstract	The statement concerned the National Institute for Occupational Safety and Health (NIOSH) investigation of occupational exposure to dibromochloropropane (96128) (DBCP) and possible reduced sperm counts among workers handling the compound. Due to the concern of one worker, a chemical company, the Oxy Chem facility in Lathrop, California, contacted NIOSH for assistance in determining whether a health problem existed at their facility. Research indicated that there was a problem and resulted in the identification of DBCP as the offending agent. Confirmation was sought by testing workers at other sites involved in the production of the pesticide. Their research supported the findings that DBCP was the agent responsible for the testicular toxicity. Literature studies revealed DBCP to be an animal carcinogen and a relatively potent mutagen as well. A proposed emergency standard for occupational exposure to DBCP was submitted to the Occupational Safety and Health Administration (OSHA) in early September of 1977 setting an exposure limit and requiring medical surveillance guidelines. A symposium on DBCP was held so that all interested parties might share available data. All participants agreed to the need for a registry of individuals exposed to DBCP. Research has now spread to the possible reproductive effects of exposure to other chemicals similar in structure to DBCP.
Keywords	Environmental surveys Industrial medicine Pesticides Government policies Chemical industry Exposure Toxicity Inspection Hazardous materials Occupational diseases Genital diseases Standards Dibromochloropropane Toxic substances Occupational safety and health Testimony Maximum permissible exposure level CAS 96-12-8
Source Agency	National Institute for Occupational Safety and Health
NTIS Subject Category	57U - Public Health & Industrial Medicine 57Y - Toxicology 68G - Environmental Health & Safety 94D - Job Environment 41I - Job Environment
Corporate Authors	National Inst. for Occupational Safety and Health, Cincinnati, OH.
Document Type	Technical Report
NTIS Issue Number	199008